Journal of Clinical Anesthesia
Volume 15, Issue 2 , Pages 154-158 , March 2003

Norepinephrine in septic patients—friend or foe?

  • Gregor Theilmeier, MD

      Affiliations

    • Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Westfälische Wilhelms-Universität, Albert-Schweitzer-Str. 33, 48129 Münster, Germany
    • Resident
    • ,
  • Michael Booke, MD, PhD

      Affiliations

    • Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Westfälische Wilhelms-Universität, Albert-Schweitzer-Str. 33, 48129 Münster, Germany
    • Corresponding Author InformationAddress correspondence to Professor Booke, Department of Anesthesiology, Kliniken des Main-Taunus-Kreises, Kronberger Str. 36, 65812 Bad Soden, FRG.
    • Professor of Anaesthesia

Received 23 July 2001 ,Accepted 10 September 2002.

References 

  1. Smulian H, Cuddy RP, Eich RH. Hemodynamic effects of pressor agents in septic and myocardial infarction shock. JAMA. 1964;190:188–192
  2. Revelly JP, Liaudet L, Frascarolo P, Joseph JM, Martinet O, Market M. Effects of norepinephrine on the distribution of intestinal blood flow and tissue adenosine triphosphate content in endotoxic shock. Crit Care Med. 2000;28:2500–2506
  3. Yang S, Zhou M, Chaudry IH, Wang P. Norepinephrine-induced hepatocellular dysfunction in early sepsis is mediated by activation of alpha2-adrenoceptors. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1014–1021
  4. Wang P, Tait SM, Chaudry IH. Sustained elevation of norepinephrine depresses hepatocellular function. Biochim Biophys Acta. 2000;1535:36–44
  5. Koo DJ, Chaudry IH, Wang P. Mechanism of hepatocellular dysfunction during sepsis (the role of gut-derived norepinephrine (review)). Int J Mol Med. 2000;5:457–465
  6. Duranteau J, Sitbon P, Teboul JL, et al.  Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med. 1999;27:893–900
  7. Chernow B, Roth BL. Pharmacologic manipulation of the peripheral vasculature in shock (clinical and experimental approaches). Circ Shock. 1986;18:141–155
  8. Michel MC, Philipp T, Brodde OE. Alpha- and beta-adrenoceptors in hypertension (molecular biology and pharmacological studies). Pharmacol Toxicol. 1992;70(6 Pt 2):S1–10
  9. Briegel J, Forst H, Haller M, et al.  Stress doses of hydrocortisone reverse hyperdynamic septic shock (a prospective, randomized, double-blind, single-center study). Crit Care Med. 1999;27:723–732
  10. Landry DW, Levin heart rate, Gallant EM et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95:1122–5
  11. Bulger EM, Maier RV. Lipid mediators in the pathophysiology of critical illness. Crit Care Med. 2000;28(Suppl 4):N27–36
  12. Bersten AD, Hersch M, Cheung H, Rutledge FS, Sibbald WJ. The effect of various sympathomimetics on the regional circulations in hyperdynamic sepsis. Surgery. 1992;112:549–561
  13. Pleiner J, Heere-Ress E, Langenberger H, et al.  Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol. 2002;22:95–100
  14. Hwang TL, Lau YT, Huang SF, Chen MF, Liu MS. Changes of alpha 1-adrenergic receptors in human liver during intraabdominal sepsis. Hepatology. 1994;20:638–642
  15. Carcillo JA, Litten RZ, Roth BL. Norepinephrine-induced phosphorylation of a 25 kd phosphoprotein in rat aorta is altered in intraperitoneal sepsis. Circ Shock. 1989;28:257–265
  16. Daveu C, Servy C, Dendane M, Marin P, Ducrocq C. Oxidation and nitration of catecholamines by nitrogen oxides derived from nitric oxide. Nitric Oxide. 1997;1:234–243
  17. Shintani F, Kinoshita T, Kanba S, et al.  Bioactive 6-nitronorepinephrine identified in mammalian brain. J Biol Chem. 1996;271:13561–13565
  18. Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA. 2000;97:9753–9758
  19. Woodman OL, Pannangpetch P. Enhancement of noradrenergic constriction of large coronary arteries by inhibition of nitric oxide synthesis in anaesthetized dogs. Br J Pharmacol. 1994;112:443–448
  20. Szabo C, Mitchell JA, Thiemermann C, Vane JR. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol. 1993;108:786–792
  21. Landin L, Lorente JA, Renes E, Canas P, Jorge P, Liste D. Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Chest. 1994;106:250–256
  22. Meyer J, Booke M, Waurick R, Prien T, Van Aken H. Nitric oxide synthase inhibition restores vasopressor effects of norepinephrine in ovine hyperdynamic sepsis. Anesth Analg. 1996;83:1009–1013
  23. Kanagy NL. Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension. Am J Physiol. 1997;273(6 Pt 2):H2756–2764
  24. Hollenberg SM, Piotrowski MJ, Parrillo JE. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. Am J Physiol. 1997;272(3 Pt 2):R969–974
  25. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz. 1995;3:2–32
  26. Nasraway SA. Sepsis research (we must change course). Crit Care Med. 1999;27:427–430
  27. LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med. 2000;28:2729–2732
  28. Sielenkamper AW, Meyer J, Kloppenburg H, Eicker K, Van Aken H. The effects of sepsis on gut mucosal blood flow in rats. Eur J Anaesthesiol. 2001;18:673–678
  29. Talmor M, Hydo L, Barie PS. Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness (effect of intensive care unit resuscitation). Arch Surg. 1999;134:81–87
  30. Liano F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int. 1998;66(Suppl):S16–24
  31. Reinelt H, Radermacher P, Kiefer P, et al.  Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med. 1999;27:325–331
  32. Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med. 2000;28:2758–2765
  33. Yamazaki T, Shimada Y, Taenaka N, Oshumi H, Takezawa J, Yoshiya I. Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis. Crit Care Med. 1982;10:432–435
  34. Ruokonen E, Takala J, Kari A, Saxen H, Mertsola J, Hansen EJ. Regional blood flow and oxygen transport in septic shock. Crit Care Med. 1993;21:1296–1303
  35. Dasta JF. Norepinephrine in septic shock (renewed interest in an old drug). DICP. 1990;24:153–156
  36. Desjars P, Pinaud M, Potel G, Tasseau F, Touze MD. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med. 1987;15:134–137
  37. Meier-Hellmann A, Specht M, Hannemann L, Hassel H, Bredle DL, Reinhart K. Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis. Intensive Care Med. 1996;22:1354–1359
  38. Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?. Chest. 1993;103:1826–1831
  39. Rudis MI, Basha MA, Zarowitz BJ. Is it time to reposition vasopressors and inotropes in sepsis?. Crit Care Med. 1996;24:525–537
  40. Marik P, Zaloga G. Prognostic value of cortisol response in septic shock. JAMA. 2000;284:308–309
  41. McBride WT, Armstrong MA, McBride SJ. Immunomodulation (an important concept in modern anaesthesia). Anaesthesia. 1996;51:465–473
  42. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve–an integrative interface between two supersystems (the brain and the immune system). Pharmacol Rev. 2000;52:595–638
  43. Tang Y, Shankar R, Gamboa M, Desai S, Gamelli RL, Jones SB. Norepinephrine modulates myelopoiesis after experimental thermal injury with sepsis. Ann Surg. 2001;233:266–275
  44. Pastores SM, Hasko G, Vizi ES, Kvetan V. Cytokine production and its manipulation by vasoactive drugs. New Horiz. 1996;4:252–264

PII: S0952-8180(02)00504-4

doi: 10.1016/S0952-8180(02)00504-4

Journal of Clinical Anesthesia
Volume 15, Issue 2 , Pages 154-158 , March 2003

Article Tools